A team of scientists and specialists from NCI at Frederick, NCI at Bethesda, the Frederick National Laboratory for Cancer Research, and Data Management Services, Inc., has developed the first method for identifying natural products that could increase the effectiveness of camptothecin-based cancer treatments.
The National Cancer Institute and Children’s Oncology Group recently opened enrollment for a new Phase II trial of personalized precision cancer therapies. Called the Pediatric Molecular Analysis for Therapy Choice (Pediatric MATCH), the trial seeks to treat children and adolescents aged 1–21 whose solid tumors have failed to respond to or re-emerged after traditional cancer treatments.
Anuk Dayaprema and Evan Yamaguchi, champions of the 2016 Student Science Jeopardy Tournament, have done it again. After a grueling competition, they emerged victorious for the second year in a row at the 2017 Student Science Jeopardy Tournament, sponsored by the Scientific Library.
Platinum Publications are selected from articles by NCI at Frederick scientists published in 42 prestigious science journals. This list represents articles published during the time period shown above, as generated from PubMed.
Articles designated as Platinum Highlights are noteworthy articles selected from among the most recently published Platinum Publications.